content

Sempre health partners with Blue cross blue shield of Arizona to help members save on Medications

Sempre Health, the leading solution for behavior-based healthcare pricing, announced a partnership with Blue Cross Blue Shield of Arizona (BCBSAZ) that features a new...

The use of positron emission tomography-computed tomography (PET/CT) to assist preclinical oncology research

Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific molecular biomarkers. It is often combined with other...

FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment of Select Patients with TGCT a Rare and Debilitating Tumor

Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO™ (pexidartinib) as the first and only treatment for adult patients with symptomatic TGCT...

Amicus Therapeutics Receives Marketing Authorization for Galafold for Fabry Disease in Argentina

Amicus Therapeutics announced that the Agency of Medicines, Food and Medical Devices (ANMAT) in Argentina has granted approval for the first-in-class, oral small molecule...

Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease

Amicus Therapeutics  announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide...

Pre-scored chip substrates provide new options for manufacturers of innovative diagnostic consumables

SCHOTT NEXTERION® PreScora will be featured at the American Association of Clinical Chemistry’s annual scientific meeting and clinical lab expo in Anaheim, Ca. Biotech companies...

Medigene AG Medigene reports financial & business results for the first six months of 2019

Medigene AG  , a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, reported on their business performance and financial results...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read